Skip to main
ESTA
ESTA logo

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 40%
Buy 40%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Holdings Inc. is poised for substantial growth, with management projecting revenue increases of over 20% annually from 2026 to 2028, stemming from market expansion, particularly with products like Mia and Preservé. Additionally, the company anticipates becoming cash flow positive by 2026, supported by improving margins and stronger-than-expected sales in the US and international markets. The overall outlook benefits from projected strong revenue growth, which is expected to enhance profitability and operational cash flow in the near term.

Bears say

Establishment Labs Holdings Inc. faces a challenging financial outlook, primarily due to expected revenue growth declining to less than 20%, fueled by disappointing sales of its Motiva implants in the U.S. market, alongside slow progress toward achieving profitability. Additional risks include the potential for an economic slowdown adversely affecting international sales, higher-than-expected complication rates, and the threat of a dilutive equity offering. Concerns raised about cosmetic outcomes of their products further complicate expectations for sales performance and market perception.

ESTA has been analyzed by 5 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 40% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Buy based on their latest research and market trends.

According to 5 analysts, ESTA has a Buy consensus rating as of Nov 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $55.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $55.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.